In case of a new diagnosis of diabetes, a mediterranean dietary regimen was suggested as first-line approach, an addition of metformin therapy and/or long-acting insulin was preferred as second-line approach, whereas the addition of a short-acting insulin was selected as third-line approach. This evidence concerns the gene INS and diabetes mellitus.